C

Cell Biotech Co Ltd
KOSDAQ:049960

Watchlist Manager
Cell Biotech Co Ltd
KOSDAQ:049960
Watchlist
Price: 13 030 KRW -0.61% Market Closed
Market Cap: 89.2B KRW

Gross Margin
Cell Biotech Co Ltd

72.5%
Current
73%
Average
63.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
72.5%
=
Gross Profit
34.4B
/
Revenue
47.5B

Gross Margin Across Competitors

No Stocks Found

Cell Biotech Co Ltd
Glance View

Market Cap
89.2B KRW
Industry
Biotechnology

Cell Biotech Co., Ltd. engages in the manufacture, research and development of probiotics lactobacillus products. The company is headquartered in Gimpo, Gyeonggi-Do. The company went IPO on 2002-12-13. The firm's products include lactic acid bacteria (LAB) powders and finished products containing LABs. Its LAB powders are used as raw materials in foods and medicines for the functions of immunization enhancement and digestion improvement. Its finished products containing LABs are used for intestinal health improvement, carcinogen inhibition, calcium supplement and others. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
10 889.02 KRW
Overvaluation 16%
Intrinsic Value
Price
C
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
72.5%
=
Gross Profit
34.4B
/
Revenue
47.5B
What is the Gross Margin of Cell Biotech Co Ltd?

Based on Cell Biotech Co Ltd's most recent financial statements, the company has Gross Margin of 72.5%.

Back to Top